Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Nov 2017
- 2715-2724 p. digital
Publication Type: Journal Article
1569-8041
10.1093/annonc/mdx404 doi
Biomarkers, Tumor--genetics Carcinoma, Non-Small-Cell Lung--drug therapy ErbB Receptors--antagonists & inhibitors Follow-Up Studies France Humans Lung Neoplasms--drug therapy Mutation Prognosis Protein Kinase Inhibitors--therapeutic use Retrospective Studies Survival Rate